| Literature DB >> 31816178 |
Yuda Turana1, Jeslyn Tengkawan1, Yook-Chin Chia2,3, Boon Wee Teo4,5, Jinho Shin6, Guru Prasad Sogunuru7,8, Arieska Ann Soenarta9, Huynh Van Minh10, Peera Buranakitjaroen11, Chen-Huan Chen12, Jennifer Nailes13, Satoshi Hoshide14, Sungha Park15, Saulat Siddique16, Jorge Sison17, Apichard Sukonthasarn18, Jam Chin Tay19, Tzung-Dau Wang20, Narsingh Verma21, Yu-Qing Zhang22, Ji-Guang Wang23, Kazuomi Kario14.
Abstract
Hypertension is an important public health concern. The prevalence keeps increasing, and it is a risk factor for several adverse health outcomes including a decline in cognitive function. Recent data also show that the prevalence of hypertension and age-related dementia is rising in Asian countries, including in the oldest old group. This study aims to discuss possible treatments for high blood pressure in the elderly and propose an optimal target for BP relative to cognitive outcomes. This review discusses several studies on related blood pressure treatments that remain controversial and the consequences if the treatment target is too low or aggressive. Longitudinal, cross-sectional, and RCT studies were included in this review. An optimum systolic blood pressure of 120-130 mm Hg is recommended, especially in nondiabetic hypertensive patients with significant risk factors. In the oldest old group of patients, hypertension might have a protective effect. The use of calcium channel blockers (CCB) and angiotensin receptor blocker (ARB) is independently associated with a decreased risk of dementia in older people. However, personalized care for patients with hypertension, especially for patients who are frail or very old, is encouraged.Entities:
Keywords: Asia; cognitive dysfunction; dementia; hypertension; oldest old
Mesh:
Substances:
Year: 2019 PMID: 31816178 PMCID: PMC8030000 DOI: 10.1111/jch.13752
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738